Vivimed Labs: Trading Window Closed from Jan 1, 2026 for Q3 FY26 Results

Vivimed Labs Limited has announced the closure of its trading window. This closure will be effective from January 1, 2026, and will remain in effect until 48 hours after the declaration of the company...

Vivimed Labs Limited has announced the closure of its trading window. This closure will be effective from January 1, 2026, and will remain in effect until 48 hours after the declaration of the company's financial results for the quarter and nine months ended December 31, 2025. The specific date for the Board Meeting to approve these financial results will be communicated in due course. This intimation is made in accordance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and the company's Code of Conduct for Prohibition of Insider Trading.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Vivimed Labs Limited in the news today?

Vivimed Labs Limited (VIVIMEDLAB) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any financial performance data or strategic information that would indicate a positive or negative sentiment.

Trading Window Disclosure
Vivimed Labs LimitedVIVIMEDLABhttps://prysm.fi/v2/analyze/VIVIMEDLAB

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Vivimed Labs: Trading Window Closed from Jan 1, 2026 for Q3 FY26 Results

December 24, 2025, 10:03 AM

AI Sentiment Analysis

Top Queries to Ask About Vivimed Labs Limited

Vivimed Labs Limited has announced the closure of its trading window. This closure will be effective from January 1, 2026, and will remain in effect until 48 hours after the declaration of the company's financial results for the quarter and nine months ended December 31, 2025.

The specific date for the Board Meeting to approve these financial results will be communicated in due course. This intimation is made in accordance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and the company's Code of Conduct for Prohibition of Insider Trading.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Vivimed Labs Limited

Discover more trending news on Prysm

View All